PCN26 - Estimating The Potential Budget Impact Of Zelboraf (Vemurafenib) For Advanced Melanoma Treatment In Brazilian Private Health Care System
Autor: | Tsuchiya, C.T., Buschinelli, C.T., M.F.M., Maximo, Tobaruella, F.S., Borges, L.G. |
---|---|
Zdroj: | In Value in Health May 2013 16(3):A132-A132 |
Databáze: | ScienceDirect |
Externí odkaz: |